Dupont Capital Management Corp Puma Biotechnology, Inc. Transaction History

Dupont Capital Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$1.64 - $3.3 $106,996 - $215,298	-65,242 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$2.13 - $3.24 $12,290 - $18,694	-5,770 Reduced 8.13%	65,242 $188,000
Q4 2021 Jan 31, 2022	BUY	$2.85 - $6.58 $202,384 - $467,258	71,012 New	71,012 $216,000
Q3 2018 Nov 05, 2018	SELL	$41.2 - $59.85 $1.71 Million - $2.49 Million	-41,560 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$48.3 - $68.25 $335,540 - $474,132	6,947 Added 20.07%	41,560 $2.46 Million
Q1 2018 May 02, 2018	BUY	$59.7 - $99.25 $1.71 Million - $2.84 Million	28,636 Added 479.1%	34,613 $2.36 Million
Q4 2017 Jan 31, 2018	BUY	$93.85 - $132.45 $560,941 - $791,653	5,977	5,977 $591,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $139M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.